abstract |
The present invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing the compound {1S-[la, 2a, 3P (1S*,2R*),5P]}-3-(7-{[2- (3,4-difluorophenyl)cyclopropyl]amino }-5-(propylthio )-3H-1,2,3-triazolo[ 4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy )cyclopentane-1,2-diol. |